Transforming Growth Factor-β1 Induced Hepatocyte Apoptosis: A Possible Mechanism for Growth of Colorectal Liver Metastasis

Acta Oncologica

Volumn 43, Issue 1, 2004, Pages 91-97

  Hayashi, Hikota ^a,b   Kohno, Hitoshi ^a   Ono, Takashi ^a   Yamanoi, Akira ^a   Dhar, Dipok K ^a   Ueda, Shuhei ^a   Rahman, Mohammad A ^a   Kubota, Hirofumi ^a   Nagasue, Naofumi ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b Masuda Medical Association Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; FAS ANTIGEN; FAS LIGAND; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER METASTASIS; LIVER PARENCHYMA; LIVER RESECTION; LIVER TUMOR; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; ANTIGENS, CD95; APOPTOSIS; BIOPSY, NEEDLE; CELLS, CULTURED; COLORECTAL NEOPLASMS; FEMALE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 1442339385     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310021527     Document Type: Article

References (29)

1. Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 2001; 7: 3298-304.
2. Shiraki K, Tsuji N, Shioda T, Isselbacher KJ, Takahashi H. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci USA 1997; 94: 6420-5.
3. Yoong KF, Afford SC, Randhawa S, Hubscher SG, Adams DH. Fas/Fas ligand interaction in human colorectal hepatic metastases: a mechanism of hepatocyte destruction to facilitate local tumor invasion. Am J Pathol 1999; 154: 693-703.
4. Roberts AB. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 1998; 24: 111-9.
5. Schuster N, Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 2002; 307: 1-14.
6. Robson H, Anderson E, James RD, Schofield PF. Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer 1996; 74: 753-8.
7. Picon A, Gold LI, Wang J, Cohen A, Friedman E. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1. Cancer Epidemiol Biomarkers Prev 1998; 7: 497-504.
8. Narai S, Watanabe M, Hasegawa H, et al. Significance of transforming growth factor β1 as a new tumor marker for colorectal cancer. Int J Cancer 2002; 97: 508-11.
9. Oberhammer FA, Pavelka M, Sharma S, et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci USA 1992; 89: 5408-12.
10. Schrum LW, Bird MA, Salcher O, et al. Autocrine expression of activated transforming growth factor-beta(1) induces apoptosis in normal rat liver. Am J Physiol 2001; 280: G139-48.
11. Takiya S, Tagaya T, Takahashi K, et al. Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases. J Clin Pathol 1995; 48: 1093-7.
12. Masunaga R, Kohno H, Dhar DK, et al. Enhanced apoptosis and transforming growth factor-beta1 expression in colorectal adenomas and carcinomas after sulindac therapy. Dis Colon Rectum 2001; 44: 1008-15.
13. Shibakita M, Tachibana M, Dhar DK, et al. Prognostic significance of Fas and Fas ligand expression in esophageal cancer. Clin Cancer Res 1999; 5: 2464-9.
14. Sugihara A, Saiki S, Tsuji M, et al. Expression of Fas and Fas ligand in the testis and testicular germ cell tumors: an immunohistochemical study. Anticancer Res 1997; 17: 3861-6.
15. Lee SH, Shin MS, Park WS, et al. Immunohistochemical analysis of Fas ligand expression in normal human tissues. APMIS 1999; 107: 1013-9.
16. Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993; 69: 415-29.
17. Koga H, Sakisaka S, Ohishi M, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor differentiation. Hepatology 1999; 29: 688-96.
18. Clark DA, Coker R. Transforming growth factor-beta (TGF-β). Int J Cell Biochem Cell Biol 1998; 30: 293-8.
19. Morkowitz S. TGF-β1 receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. Biochem Biophys Acta 2000; 1470: M13-20.
20. Roman C, Saha D, Beauchamp R. TGF-beta and colorectal carcinogenesis. Microsc Res Tech 2001; 52: 450-7.
21. Parsons R, Myeroff LL, Liu B, Willson JKV, et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995; 55: 5548-50.
22. Grady WM, Myeroff LL, Swinler SE, et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 1999; 59: 320-4.
23. Tsushima H, Ito N, Tamura S, Matsuda Y, et al. Circulating transforming growth factor β1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res 2001; 7: 1258-62.
24. Paik SY, Park YN, Kim H, Park C. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules. Mod Pathol 2003; 16: 86-96.
25. Nishibori H, Watanabe M, Narai S, et al. An interaction between human colon carcinoma cells and hepatocytes activates transforming growth factor-beta1 in vitro. Cancer Lett 1999; 142: 83-9.
26. Gressner AM, Lahme B, Mannherz HG, Polzar B. TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 1997; 26: 1079-92.
27. Gutierrez JA, Perr HA. Mechanical stretch modulates TGF-beta1 and alpha1(I) collagen expression in fetal human intestinal smooth muscle cells. Am J Physiol 1999; 277: G1074-80.
28. Gorelik L, Flavell RA. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β1 signaling in T cells. Nat Med 2001; 7: 1118-22.
29. Leu JI, Crissey MA, Taub R. Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 2003; 111: 129-39.